drugset / Trial / NCT02155205
A Thorough QT Study of Telotristat Etiprate
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to demonstrate that telotristat etiprate does not differ from placebo in the mean change from Baseline QT interval corrected for heart rate.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | Telotristat etiprate | Unknown | 1500 mg | — |
Indications
No indication recorded.